Sources

[←1]

^{Berger, Christian, et al. “Massive accumulation of N‐acylethanolamines after stroke. Cell signaling in acute cerebral ischemia?.” Journal of neurochemistry 88.5 (2004): 1159-1167.///}

[←2]

^{Hansen HH, Ikonomidou C, Bittigau P, et al. Accumulation of the anandamide precursor and other N-acylethanolamine phospholipids in infant rat models of in vivo necrotic and apoptotic neuronal death. J Neurochem 2001;76:39–46.///}

[←3]

^{Panikashvili, David, et al. “An endogenous cannabinoid (2-AG) is neuroprotective after brain injury.” Nature 413.6855 (2001): 527-531.}

[←4]

^{Kim SH, Won SJ, Mao XO, et al. Molecular mechanisms of cannabinoid protection from neuronal excitotoxicity. Mol Pharmacol 2006;69:691–6///}

[←5]

^{Marsicano G, Goodenough S, Monory K, et al. CB1 cannabinoid receptors and on-demand defense against excitotoxicity. Science 2003;302:84–8///}

[←6]

^{van der Stelt, Mario, et al. “Acute neuronal injury, excitotoxicity, and the endocannabinoid system.” Molecular neurobiology 26.2-3 (2002): 317-346.}

[←7]

^{Klein, Thomas W. “Cannabinoid-based drugs as anti-inflammatory therapeutics.” Nature Reviews Immunology 5.5 (2005): 400-411.//Murikinati S, Juttler E, Keinert T, et al. Activation of cannabinoid 2 receptors protects against cerebral ischemia by inhibiting neutrophil recruitment. FASEB J 2010;24:788–98.///}

[←8]

^{Walter, Lisa, and Nephi Stella. “Cannabinoids and neuroinflammation.” British journal of pharmacology 141.5 (2004): 775-785.//Guzmán, Manuel, Cristina Sánchez, and Ismael Galve-Roperh. “Control of the cell survival/death decision by cannabinoids.” Journal of Molecular Medicine 78.11 (2001): 613-625//}

[←9]

^{Galve-Roperh, Ismael, et al. “Mechanisms of control of neuron survival by the endocannabinoid system.” Current pharmaceutical design 14.23 (2008): 2279-2288.///}

[←10]

^{Ramirez, Servio H., et al. “Activation of cannabinoid receptor 2 attenuates leukocyte–endothelial cell interactions and blood–brain barrier dysfunction under inflammatory conditions.” The Journal of Neuroscience 32.12 (2012): 4004-4016./// 11}

[←11]

^{Viscomi MT, Oddi S, Latini L, et al. Selective CB2 receptor agonism protects central neurons from remote axotomy-induced apoptosis through the PI3K/Akt pathway. J Neurosci 2009;29:4564–70}

[←12]

^{Alonso-Alconada, D., et al. “The cannabinoid WIN 55212-2 mitigates apoptosis and mitochondrial dysfunction after hypoxia ischemia.” Neurochemical research 37.1 (2012): 161-170.}

[←13]

^{Alonso-Alconada D, Alvarez FJ, Alvarez A, et al. The cannabinoid receptor agonist WIN 55,212-2 reduces the initial cerebral damage after hypoxic-ischemic injury in fetal lambs. Brain Res 2010;1362:150–9.}

[←14]

^{Fernández-López, David, et al. “The cannabinoid agonist WIN55212 reduces brain damage in an in vivo model of hypoxic-ischemic encephalopathy in newborn rats.” Pediatric research 62.3 (2007): 255-260.}

[←15]

^{Fernández-López, David, et al. “The cannabinoid WIN55212-2 promotes neural repair after neonatal hypoxia–ischemia.” Stroke 41.12 (2010): 2956-2964.}

[←16]

^{Lafuente H, Alvarez FJ, Pazos MR, et al. Cannabidiol reduces brain damage and improves functional recovery after acute hypoxia-ischemia in newborn pigs. Pediatr Res 2011;70:272–7.}

[←17]

^{Nguyen, Brian M., et al. “Effect of marijuana use on outcomes in traumatic brain injury.” The American Surgeon 80.10 (2014): 979-983.}